We are monitoring the impact of COVID-19 on Sleep Aids Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1706
Share on
Share on

Global Sleep Aids Market Size, Share, Trends, COVID-19 Impact & Growth Forecast Report - Segmented By Sleep Order, Product, Medication Type, and Region - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1706
Pages: 173

Global Sleep Aids Market Size (2021 to 2026)

The global sleep aids market size is predicted to worth USD 97.31 billion by 2026 from USD 71.63 billion in 2021, registering a  CAGR of 6.32% during the forecast period.

Sleep aids are mainly to help people who are suffering from sleeping disorders. These are the medications or herbs which allow a person to get rest. Sleep aids will block some brain chemicals, making a person sleep, while some medicines will later change the body’s natural circadian rhythms. As sleep is the most common thing for health factors and enables many organs to function healthy, sleep aids will reduce long-term health disorders. Herbs and natural compounds included in natural remedies also play a crucial role in maintaining a healthy sleep cycle.

MARKET DRIVERS:

Growing incidences of sleeping difficulties among people due to lifestyle changes are majorly accelerating the growth rate of the global sleep aids market.

Shifting trends to maintain a healthy lifestyle by maintaining a good sleep cycle is lavishing this market's demand to the extent. The increasing geriatric population also propels the sleep aids market. Nowadays, people are experiencing many health disorders due to lack of proper sleep, which may be due to hectic works, stress, and others, which is also an attribute accelerating the demand of the global sleep aids market.

A rise in the popularity of over-the-counter drugs, which can be available easily from the pharmaceutical stores, is anticipated to create growth opportunities for the market. Adopting newly launched therapeutic devices, especially in developed and developing countries, is ascribed to bolster the demand for the sleep aids market. The emergence of advanced technologies for treating sleep disorders, including monitoring and diagnosing, significantly influences the market shares towards positive. On-going research on developing innovative drugs with adequate quality and reducing complications certainly fuels the demand for the sleep aids market. The availability of healthcare professionals in analyzing the ill effects of sleep disorders will also help manufacture effective sleep aids devices.

MARKET RESTRAINTS:

However, fluctuations in raw materials' availability, mostly natural products, slowly degrade the market demand. The rise in the number of patients with side effects due to the long-term use of these medications has remained challenging for the market. Besides, lack of complete knowledge over the dosage forms while manufacturing the products in undeveloped countries inhibits the demand of the sleep aids market. Stringent rules and regulations by the government on pharmaceutical companies may also negatively impact the growth rate of the sleep aids market.

COVID-9 impact on the sleep aids market:

COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2, has spread exponentially across the world since late December 2019, causing unprecedented changes in health care systems.

According to a study of medrxiv.org, a significant spike in the prevalence of mental health problems has been noticed during the lockdown period caused by the coronavirus. Sleep disorders are one of the major mental health problems. As the fact says, solid sleep is much essential for individuals' physical and mental well-being. But it is often neglected, which resulted in a high incidence of sleep disorders across the globe.

COVID-19 harms the worldwide sleeping aids market growth in 2020, providing a slight decline in its growth rate. Medication, sleep laboratories, sleep apnea devices, and mattresses and pillows are types of sleep aids. Consequently, the lockdown trade-in of several products, including sleeping aids, has been limited, as has individual monthly wages, the shutdown of processing plants protects workers in all countries. Sleep aids are medications and surgical instruments used to detect and cure a variety of sleep disorders. Increasing working hours, a heavy workload and job burden, and a hectic work environment contribute to high stress and poor sleep quality. These sleep disturbances are expected to harm human health and contribute to various chronic diseases such as high blood pressure, diabetes, asthma, affecting immune systems, etc. This increases the sales of over-the-counter sleeping pills, which help improve sleep quality around the world. As a result, it is important to treat and diagnose these diseases at an early stage. Furthermore, growing advances in sleep assist devices, emerging treatments for insufficient sleep, and the rising use of portable sleep apnea devices are expected to contribute to the growth of the global sleep aids market in coming years.

Considering the present situation, analysts at MarketDataForecast predicted that the future of the global sleep aids market is expected to be more promising, and COVID-19 favored the market growth.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Sleep disorder, Product, Medication Type, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

 

This research report on the global sleep aids market has been segmented and sub-segmented based on sleep disorder, product, medication type, and region.

Sleep Aids Market - By Sleep Disorder:

  • Insomnia
  • Sleep Apnea
  • Restless legs syndrome
  • Narcolepsy
  • Sleepwalking

Based on sleep disorder, the insomnia segment accounts for a significant share globally in the sleep aids market during the forecast period. 10 % to 30% of adults and up to 50% to 60% suffer from insomnia annually, according to a study published by the International Journal of Contemporary Medical Research (IJCMR). The incidence of insomnia in people increases due to work stress, depression, anxiety disorders, excessive smoking, and alcohol consumption.

The sleep apnea segment remains the fastest-growing segment than other sleep disorders due to the growing aging population, who are more vulnerable to sleep apnea disorders, growing manufacturing processes, and existing market economies.

The sleepwalking and restless Legs Syndrome segment are forecasted to have prominent growth during the forecast period. Increasing sleepwalking and restless syndrome cases have covered the inflow of voluminous growth in the sleep aids market globally.

Sleep Aids Market - By Product:

Based on the product, the mattresses and pillows segments are expected to continue leading the sleep aids market in the coming years. The segment is majorly driven by the wide features such as comfortable, conformity, accessibility of different products, and relatively cheap. Also, increasing awareness regarding the health advantages of quality sleep amid the rise in population accelerates the Sleep aids market growth globally during the assessment period.

Sleep Aids Market - By Medication Type:

  • Prescription-based Drugs
  • OTC drugs
  • Herbal Drugs

Based on medication type, prescription medications hold the largest share in the market. People suffering from lack of sleep and sleep disorders are increasing globally, which is anticipated to fuel the market's demand.

Sleep Aids Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the global sleep aids market was dominated by North America in 2020, with an overall market share of over 50% globally. Europe and Asia-Pacific followed North America. Asia Pacific is expected to exhibit a CAGR of almost 6.9% against North America’s CAGR of 5.9% over the coming years.

The North American market is predicted to occupy most of the share in the global market due to the quick adoption of the latest technologies. Focus on developing new techniques with herbs and natural products with fewer or no side effects is gaining traction over the market shares.

The European market is positioned next to North America in ruling with dominant shares of the sleeping aids market. An increasing number of sleep apnea cases across the region is eventually making the market grow. Creating awareness over the availability of different treatment procedures for sleep disorders boosts the market demand in this region.

The Asia Pacific market is expected to hit the highest CAGR in the coming years. The rise in the consumption rate of tobacco and alcohol is leveraging the market demand in this region. India and China are major countries contributing to the largest shares of the sleep aids market.

KEY MARKET PARTICIPANTS:

Some of the notable companies dominating the global sleep aids market profiled in this report are Sanofi, Merck & Co, Pfizer, Koninklijke Philips N.V. (Philips), GlaxoSmithKline Plc, Care Fusion Corporation, Cadwell, SleepMed, Natus Medical Manufactures, and DeVilbiss Healthcare LLC.

RECENT MARKET HAPPENINGS:

  • In July 2019, generic Ramelteon tablets of 8mg strength were launched by Dr. Reddy’s Laboratories, which treat insomnia.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Sleep Disorder                          

                                5.1.1 Introduction           

                                5.1.2 Insomnia  

                                5.1.3 Sleep Apnea           

                                5.1.4 Restless legs syndrome     

                                5.1.5 Narcolepsy              

                                5.1.6 Sleep Walking        

                                5.1.6  Y-o-Y Growth Analysis, By Sleep Disorder

                                5.1.7  Market Attractiveness Analysis, By Sleep Disorder               

                                5.1.8  Market Share Analysis, By Sleep Disorder                

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Mattresses & Pillows          

                                5.2.3 Sleep Laboratories               

                                5.2.4 Medications           

                                5.2.5 Sleep apnea devices           

                                5.2.6 Y-o-Y Growth Analysis, By Product               

                                5.2.7 Market Attractiveness Analysis, By Product             

                                5.2.8 Market Share Analysis, By Product               

                5.3 Medication                 

                                5.3.1 Introduction           

                                5.3.2 Prescription-based Drugs 

                                5.3.3 OTC Drugs               

                                5.3.4 Herbal Drugs          

                                5.3.5 Y-o-Y Growth Analysis, By Medication        

                                5.3.6  Market Attractiveness Analysis, By Medication     

                                5.3.7  Market Share Analysis, By Medication       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Sleep Disorder

                                                6.1.3.3 By Product

                                                6.1.3.4 By Medication

                                                6.1.3.5 By Indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Sleep Disorder

                                                6.1.4.3 By Product

                                                6.1.4.4 By Medication

                                                6.1.4.5 By Indication

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Sleep Disorder

                                                6.1.5.3 By Product

                                                6.1.5.4 By Medication

                                                6.1.5.5 By Indication

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Sanofi                           

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Merck & Co                

                8.3 Pfizer                            

                8.4 Koninklijke Philips N.V.                          

                8.5 GlaxoSmithKline Plc                

                8.6 Care Fusion Corporation                       

                8.7 Cadwell                        

                8.8 Sleepmed                   

                8.9 Natus Medical Manufacturers                            

                8.10 DeVilbiss Healthcare LLC                     

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Sleep Aids Market, By Region, From 2021 to 2026 (USD Million)
  2. Global Sleep Aids Market, By Sleep Disorde, From 2019-2024 (USD Billion 
  3. Global Insomnia Market, By Region, From 2021 to 2026 (USD Million)
  4. Global Sleep Apnea Market, By Region, From 2021 to 2026 (USD Million)
  5. Global Restless Legs Syndrome Market, By Region, From 2021 to 2026 (USD Million)
  6. Global Narcolepsy  Market, By Region, From 2021 to 2026 (USD Million)
  7. Global Sleep Walking Market, By Region, From 2021 to 2026 (USD Million)
  8. Global Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  9. Global Mattresses & Pillows Market, By Region, From 2021 to 2026 (USD Million)
  10. Global Sleep Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  11. Global Medication Market, By Region, From 2021 to 2026 (USD Million)
  12. Global Sleep Apnea Devices Market, By Region, From 2021 to 2026 (USD Million)
  13. Global Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  14. Global Prescription-based Drugs Market, By Region, From 2021 to 2026 (USD Million)
  15. Global OTC drugs Market, By Region, From 2021 to 2026 (USD Million)
  16. Global Herbal Drugs Market, By Region, From 2021 to 2026 (USD Million)
  17. North America Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  18. North America Insomnia Market, By Region, From 2021 to 2026 (USD Million)
  19. North America Sleep Apnea Market, By Region, From 2021 to 2026 (USD Million)
  20. North America Restless Legs Syndrome Market, By Region, From 2021 to 2026 (USD Million)
  21. North America Narcolepsy  Market, By Region, From 2021 to 2026 (USD Million)
  22. North America Sleep Walking Market, By Region, From 2021 to 2026 (USD Million)
  23. North America Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  24. North America Mattresses & Pillows Market, By Region, From 2021 to 2026 (USD Million)
  25. North America Sleep Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  26. North America Medication Market, By Region, From 2021 to 2026 (USD Million)
  27. North America Sleep Apnea Devices Market, By Region, From 2021 to 2026 (USD Million)
  28. North America Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  29. North America Prescription-based Drugs Market, By Region, From 2021 to 2026 (USD Million)
  30. North America OTC drugs Market, By Region, From 2021 to 2026 (USD Million)
  31. North America Herbal Drugs Market, By Region, From 2021 to 2026 (USD Million)
  32. United States Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  33. United States Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  34. United States Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  35. Canada Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  36. Canada Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  37. Canada Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  38. Europe Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  39. Europe Insomnia Market, By Region, From 2021 to 2026 (USD Million)
  40. Europe Sleep Apnea Market, By Region, From 2021 to 2026 (USD Million)
  41. Europe Restless Legs Syndrome Market, By Region, From 2021 to 2026 (USD Million)
  42. Europe Narcolepsy  Market, By Region, From 2021 to 2026 (USD Million)
  43. Europe Sleep Walking Market, By Region, From 2021 to 2026 (USD Million)
  44. Europe Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  45. Europe Mattresses & Pillows Market, By Region, From 2021 to 2026 (USD Million)
  46. Europe Sleep Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  47. Europe Medication Market, By Region, From 2021 to 2026 (USD Million)
  48. Europe Sleep Apnea Devices Market, By Region, From 2021 to 2026 (USD Million)
  49. Europe Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  50. Europe Prescription-based Drugs Market, By Region, From 2021 to 2026 (USD Million)
  51. Europe OTC drugs Market, By Region, From 2021 to 2026 (USD Million)
  52. Europe Herbal Drugs Market, By Region, From 2021 to 2026 (USD Million)
  53. U.K. Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  54. U.K. Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  55. U.K. Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  56. Germany Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  57. Germany Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  58. Germany Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  59. France Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  60. France Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  61. France Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  62. Italy Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  63. Italy Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  64. Italy Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  65. Spain Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  66. Spain Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  67. Spain Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  68. Asia-Pacific Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  69. Asia-Pacific Insomnia Market, By Region, From 2021 to 2026 (USD Million)
  70. Asia-Pacific Sleep Apnea Market, By Region, From 2021 to 2026 (USD Million)
  71. Asia-Pacific Restless Legs Syndrome Market, By Region, From 2021 to 2026 (USD Million)
  72. Asia-Pacific Narcolepsy  Market, By Region, From 2021 to 2026 (USD Million)
  73. Asia-Pacific Sleep Walking Market, By Region, From 2021 to 2026 (USD Million)
  74. Asia-Pacific Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  75. Asia-Pacific Mattresses & Pillows Market, By Region, From 2021 to 2026 (USD Million)
  76. Asia-Pacific Sleep Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  77. Asia-Pacific Medication Market, By Region, From 2021 to 2026 (USD Million)
  78. Asia-Pacific Sleep Apnea Devices Market, By Region, From 2021 to 2026 (USD Million)
  79. Asia-Pacific Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  80. Asia-Pacific Prescription-based Drugs Market, By Region, From 2021 to 2026 (USD Million)
  81. Asia-Pacific OTC drugs Market, By Region, From 2021 to 2026 (USD Million)
  82. Asia-Pacific Herbal Drugs Market, By Region, From 2021 to 2026 (USD Million)
  83. Japan Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  84. Japan Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  85. Japan Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  86. China Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  87. China Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  88. China Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  89. India Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  90. India Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  91. India Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  92. Australia Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  93. Australia Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  94. Australia Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  95. South Korea Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  96. South Korea Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  97. South Korea Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  98. Latin America Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  99. Latin America Insomnia Market, By Region, From 2021 to 2026 (USD Million)
  100. Latin America Sleep Apnea Market, By Region, From 2021 to 2026 (USD Million)
  101. Latin America Restless Legs Syndrome Market, By Region, From 2021 to 2026 (USD Million)
  102. Latin America Narcolepsy  Market, By Region, From 2021 to 2026 (USD Million)
  103. Latin America Sleep Walking Market, By Region, From 2021 to 2026 (USD Million)
  104. Latin America Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  105. Latin America Mattresses & Pillows Market, By Region, From 2021 to 2026 (USD Million)
  106. Latin America Sleep Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  107. Latin America Medication Market, By Region, From 2021 to 2026 (USD Million)
  108. Latin America Sleep Apnea Devices Market, By Region, From 2021 to 2026 (USD Million)
  109. Latin America Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  110. Latin America Prescription-based Drugs Market, By Region, From 2021 to 2026 (USD Million)
  111. Latin America OTC drugs Market, By Region, From 2021 to 2026 (USD Million)
  112. Latin America Herbal Drugs Market, By Region, From 2021 to 2026 (USD Million)
  113. Brazil Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  114. Brazil Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  115. Brazil Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  116. Argentina Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  117. Argentina Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  118. Argentina Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  119. Mexico Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  120. Mexico Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  121. Mexico Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  122. Rest of Latin America Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  123. Rest of Latin America Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  124. Rest of Latin America Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  125. Middle East & Africa Sleep Aids Market, By Sleep Disorde, From 2021 to 2026 (USD Million)
  126. Middle East & Africa Insomnia Market, By Region, From 2021 to 2026 (USD Million)
  127. Middle East & Africa Sleep Apnea Market, By Region, From 2021 to 2026 (USD Million)
  128. Middle East & Africa Restless Legs Syndrome Market, By Region, From 2021 to 2026 (USD Million)
  129. Middle East & Africa Narcolepsy  Market, By Region, From 2021 to 2026 (USD Million)
  130. Middle East & Africa Sleep Walking Market, By Region, From 2021 to 2026 (USD Million)
  131. Middle East & Africa Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  132. Middle East & Africa Mattresses & Pillows Market, By Region, From 2021 to 2026 (USD Million)
  133. Middle East & Africa Sleep Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  134. Middle East & Africa Medication Market, By Region, From 2021 to 2026 (USD Million)
  135. Middle East & Africa Sleep Apnea Devices Market, By Region, From 2021 to 2026 (USD Million)
  136. Middle East & Africa Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  137. Middle East & Africa Prescription-based Drugs Market, By Region, From 2021 to 2026 (USD Million)
  138. Middle East & Africa OTC drugs Market, By Region, From 2021 to 2026 (USD Million)
  139. Middle East & Africa Herbal Drugs Market, By Region, From 2021 to 2026 (USD Million)
  140. Middle East Sleep Aids Market, By Sleep Disorder, From 2021 to 2026 (USD Million)
  141. Middle East Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  142. Middle East Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)
  143. Africa Sleep Aids Market, By Sleep Disorder, From 2021 to 2026 (USD Million)
  144. Africa Sleep Aids Market, By Product, From 2021 to 2026 (USD Million)
  145. Africa Sleep Aids Market, By Medication, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample